Live Breaking News & Updates on European Society For Medical Oncology

Stay updated with breaking news from European society for medical oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors

U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Madrid , Spain , Susan-spinosa , Alexander-drilon , Nick-botwood , Bristol-myers-squibb , National-cancer-institute , Linkedin , Drug-administration , Twitter , Instagram , Exchange-commission

U.S. Food and Drug Administration Approves Augtyrotm (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Augtyrotm (repotrectinib) for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that. ....

Spain , Madrid , Bristol-myers-squibb , Nick-botwood , Alexander-drilon , Susan-spinosa , Linkedin , Drug-administration-approves-augtyrotm , Youtube , Facebook , National-cancer-institute , Instagram

Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes. ....

China , Yu-chen , Zhejiang , Suzhou , Jiangsu , Fujian , Rhui-zhou , Guangdong , Australia , United-states , Innovent-biologics , Tingbo-liang

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Barcelona , Comunidad-autonoma-de-cataluna , Spain , Switzerland , Paris , France-general , France , Texas , United-states , Chicago , Illinois , Lugano

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

China , Beijing , Yan-wang , Shaanxi , Fujian , Ying-cheng , Hubei , Lanzhou , Gansu , Jilin , Shanxi , Yinchuan